Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4012024011 | Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4012025012 | Pyrantel (as pyrantel pamoate) 50 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 4860551000052117 | pyrantel (som pyrantelpamoat) 50 mg/ml, oral suspension | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Pyrantel-containing product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Pyrantel pamoate | true | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | har nämnarvärde som visar koncentrationsstyrka | 1 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Pyrantel (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | har täljarvärde för koncentrationsstyrka | 50 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely pyrantel (as pyrantel pamoate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Anthelmintic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR